How much does brigatinib/brigatinib targeted drug cost in 2024?

Brigatinib is a cancer drug used to treat non-small cell lung cancer (NSCLC) in adults. It is used in patients who have never been treated with ALK inhibitor drugs before or who have been previously treated with the ALK inhibitor crizotinib. Brigatinib is used to treat NSCLC only if it is "ALK positive," meaning something has changed in the cancer cells that affects the gene that produces a protein called ALK (anaplastic lymphoma kinase).

ALK belongs to a family of enzymes called receptor tyrosine kinases, which are involved in cell growth and the development of new blood vessels that supply the cells. Patients with ALK-positive non-small cell lung cancer produce an abnormal form of ALK that stimulates cancer cells to divide and grow in an uncontrolled manner. The active substance in brigatinib works by blocking the activity of ALK, thereby reducing the growth and spread of cancer.

The original brigatinib drug has been launched in China and has been included in the Class B medical insurance. Common specifications include 30mg*14 tablets*2 boards, 90mg*7 tablets*4 boards, 90mg*7 tablets, 180mg*7 tablets*4 boards, etc. The price of each box may range from RMB 10,000, which is relatively expensive. Currently, relatively cheap generic brigatinib drugs are also sold overseas, and their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 90mg*30 tablets produced by a Bangladesh pharmaceutical factory is around 2,000 yuan per box (the price may fluctuate due to exchange rates). For more drug information and specific prices, please consult Yaode Medical Consultant.